These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9501890)

  • 1. Seizure during risperidone treatment in an elderly woman treated with concomitant medications.
    Lane HY; Chang WH; Chou JC
    J Clin Psychiatry; 1998 Feb; 59(2):81-2. PubMed ID: 9501890
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical guidelines: Dosing and switching strategies for long-acting risperidone.
    Marder SR; Conley R; Ereshefsky L; Kane JM; Turner MS
    J Clin Psychiatry; 2003; 64 Suppl 16():41-6. PubMed ID: 14680418
    [No Abstract]   [Full Text] [Related]  

  • 3. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia".
    Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y
    J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute dystonic reaction with risperidone.
    Takhar J; Manchanda R
    Can J Psychiatry; 1996 Feb; 41(1):61-2. PubMed ID: 8919428
    [No Abstract]   [Full Text] [Related]  

  • 5. Hoarding and clozapine-risperidone combination.
    Chong SA; Tan CH; Lee HS
    Can J Psychiatry; 1996 Jun; 41(5):315-6. PubMed ID: 8793152
    [No Abstract]   [Full Text] [Related]  

  • 6. Dose-dependent acute excessive weight gain and metabolic changes in a drug-naive patient on risperidone are reversible with discontinuation: a case report.
    Sahoo S; Mishra B; Akhtar S
    Br J Clin Pharmacol; 2007 Nov; 64(5):715-6. PubMed ID: 17509037
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with risperidone and occurrence of blurred vision: a question of higher dosage.
    Uzun S; Kozumplik O; Folnegović-Smalc V; Jukić V; Petrinović-Doresić J; Dorn L; Milas DZ; Mimica N
    Can J Psychiatry; 2004 Sep; 49(9):647. PubMed ID: 15503746
    [No Abstract]   [Full Text] [Related]  

  • 8. Risperidone-induced edema.
    Ravasia S
    Can J Psychiatry; 2001 Jun; 46(5):453-4. PubMed ID: 11441789
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching between clozapine and risperidone treatment.
    Gardner DM; Baldessarini RJ; Benzo J; Zarate CA; Tohen M
    Can J Psychiatry; 1997 May; 42(4):430-1. PubMed ID: 9161773
    [No Abstract]   [Full Text] [Related]  

  • 11. Risperidone-induced priapism in a 12-year-old boy with schizophrenia.
    Prabhuswamy M; Srinath S; Girimaji S; Seshadri S
    J Child Adolesc Psychopharmacol; 2007 Aug; 17(4):539-40. PubMed ID: 17822349
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone and the treatment of delusions of parasitosis in an elderly patient.
    Gallucci G; Beard G
    Psychosomatics; 1995; 36(6):578-80. PubMed ID: 7501790
    [No Abstract]   [Full Text] [Related]  

  • 13. A pilot double-blind, dose-comparison study of risperidone in drug-naive, first-episode schizophrenia.
    Lane HY; Chang WH; Chiu CC; Huang MC; Lee SH; Chen JY
    J Clin Psychiatry; 2001 Dec; 62(12):994-5. PubMed ID: 11780884
    [No Abstract]   [Full Text] [Related]  

  • 14. Risperidone, weight gain, and bulimia nervosa.
    Crockford DN; Fisher G; Barker P
    Can J Psychiatry; 1997 Apr; 42(3):326-7. PubMed ID: 9114956
    [No Abstract]   [Full Text] [Related]  

  • 15. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW; Shin IS; Kim JM; Yang SJ; Hwang MY; Yoon JS
    J Clin Psychopharmacol; 2008 Jun; 28(3):349-52. PubMed ID: 18480697
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of schizophrenia with depot preparations of fluphenazine, haloperidol, and risperidone among inpatients at state-operated psychiatric facilities.
    Citrome L; Jaffe A; Levine J
    Schizophr Res; 2010 Jun; 119(1-3):153-9. PubMed ID: 20347267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A cross-sectional study of plasma risperidone levels with risperidone long-acting injectable: implications for dopamine D2 receptor occupancy during maintenance treatment in schizophrenia.
    Ikai S; Remington G; Suzuki T; Takeuchi H; Tsuboi T; Den R; Hirano J; Tsunoda K; Nishimoto M; Watanabe K; Mimura M; Mamo D; Uchida H
    J Clin Psychiatry; 2012 Aug; 73(8):1147-52. PubMed ID: 22967779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A case of resistant schizophrenia responding at a higher than recommended dose of risperidone without significant side effects.
    Ray A; Mukherjee B
    Indian J Pharmacol; 2013; 45(1):100-1. PubMed ID: 23543286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risperidone for adolescent schizophrenia.
    Jainer AK; Mahmood A
    Br J Psychiatry; 2009 Jun; 194(6):568-9; author reply 569. PubMed ID: 19478315
    [No Abstract]   [Full Text] [Related]  

  • 20. Worsening of myasthenia gravis after administration of injectable long-acting risperidone for treatment of schizophrenia; first case report and a call for caution.
    Al-Hashel JY; Ismail II; John JK; Ibrahim M; Ali M
    Neuromuscul Disord; 2016; 26(4-5):309-11. PubMed ID: 27012182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.